U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 23

1.
LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis
Yang Shen, Mengmeng Lv, Yichen Fang, Jin Lu, Yuzhong Wu
J Ovarian Res. 2021; 14: 161. Published online 2021 Nov 17. doi: 10.1186/s13048-021-00910-0
PMCID:
PMC8596928
ArticlePDF–16M
2.
Analysis of the Applicability of microRNAs in Peripheral Blood Leukocytes as Biomarkers of Sensitivity and Exposure to Fractionated Radiotherapy towards Breast Cancer
Michal Marczyk, Joanna Polańska, Andrzej Wojcik, Lovisa Lundholm
Int J Mol Sci. 2021 Aug; 22(16): 8705. Published online 2021 Aug 13. doi: 10.3390/ijms22168705
PMCID:
PMC8395710
ArticlePDF–1.1M
3.
LINC01116 promotes the proliferation and invasion of glioma by regulating the microRNA-744-5p-MDM2-p53 axis
Li Jiang, Chao Cheng, Wei Ji, Hao Wang, Quan Du, Xiaoqiao Dong, Junfei Shao, Wenhua Yu
Mol Med Rep. 2021 May; 23(5): 366. Published online 2021 Mar 16. doi: 10.3892/mmr.2021.12005
PMCID:
PMC7986001
ArticlePDF–1.7M
4.
Reduction of miR-744 delivered by NSCLC cell-derived extracellular vesicles upregulates SUV39H1 to promote NSCLC progression via activation of the Smad9/BMP9 axis
Liming Gao, Qi Tian, Tong Wu, Shanshan Shi, Xiaobo Yin, Lijie Liu, Lei Zheng, Ping Wang, Yaling Tian, Shufeng Xu
J Transl Med. 2021; 19: 37. Published online 2021 Jan 20. doi: 10.1186/s12967-020-02654-9
PMCID:
PMC7816389
ArticlePDF–1.8M
5.
MicroRNA-744-5p is downregulated in colorectal cancer and targets SEPT2 to suppress the malignant phenotype
Wei Zhang, Kai Liao, Dongning Liu
Mol Med Rep. 2021 Jan; 23(1): 54. Published online 2020 Nov 16. doi: 10.3892/mmr.2020.11692
PMCID:
PMC7705998
ArticlePDF–1.1M
6.
miR-744-5p contributes to ocular inflammation in patients with primary Sjogrens Syndrome
Qistina Pilson, Siobhan Smith, Caroline A. Jefferies, Joan Ní Gabhann-Dromgoole, Conor C. Murphy
Sci Rep. 2020; 10: 7484. Published online 2020 May 4. doi: 10.1038/s41598-020-64422-5
PMCID:
PMC7198540
ArticlePDF–1.6M
7.
Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2
Guanghui Wang, Wei Zhao, Huxia Wang, Guanglin Qiu, Zhengdong Jiang, Guangbing Wei, Xuqi Li
Med Sci Monit. 2019; 25: 7209–7217. Published online 2019 Sep 25. doi: 10.12659/MSM.919219
PMCID:
PMC6777417
ArticlePDF–2.0M
8.
MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells
Michael Kleemann, Helga Schneider, Kristian Unger, Philip Sander, E. Marion Schneider, Pamela Fischer-Posovszky, René Handrick, Kerstin Otte
Sci Rep. 2018; 8: 9020. Published online 2018 Jun 13. doi: 10.1038/s41598-018-27438-6
PMCID:
PMC5998049
ArticlePDF–6.5M
9.
Clinical relevance of microRNA expressions in breast cancer validated using the cancer genome atlas (TCGA)
Sara Y Kim, Tsutomu Kawaguchi, Li Yan, Jessica Young, Kazuaki Takabe
Ann Surg Oncol. Author manuscript; available in PMC 2018 Mar 6.
Published in final edited form as: Ann Surg Oncol. 2017 Oct; 24(10): 2943–2949. Published online 2017 Aug 1. doi: 10.1245/s10434-017-5984-2
PMCID:
PMC5839328
ArticlePDF–1.1M
10.
MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling
Han Guan, Chunhui Liu, Fang Fang, Yeqing Huang, Tao Tao, Zhixin Ling, Zonghao You, Xu Han, Shuqiu Chen, Bin Xu, Ming Chen
Oncotarget. 2017 Feb 28; 8(9): 14693–14707. Published online 2017 Jan 18. doi: 10.18632/oncotarget.14711
PMCID:
PMC5362436
ArticlePDF–11M
11.
Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism
Zhou Sha, Xiaoxia Zhu, Na Li, Yiyi Li, Dianhe Li
Oncotarget. 2016 Oct 4; 7(40): 64977–64986. Published online 2016 Aug 13. doi: 10.18632/oncotarget.11285
PMCID:
PMC5323131
ArticlePDF–14M
12.
MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma
John Zeng-Hong Li, Wei Gao, Wen-Bin Lei, Jing Zhao, Jimmy Yu-Wai Chan, William Ignace Wei, Wei-Kuen Ho, Thian-Sze Wong
Oncotarget. 2016 Sep 6; 7(36): 58218–58233. Published online 2016 Aug 13. doi: 10.18632/oncotarget.11280
PMCID:
PMC5295426
ArticlePDF–8.1M
13.
Association of MicroRNAs and YRNAs with Platelet Function
Dorothee Kaudewitz, Philipp Skroblin, Lukas H. Bender, Temo Barwari, Peter Willeit, Raimund Pechlaner, Nicholas P. Sunderland, Karin Willeit, Allison C. Morton, Paul C. Armstrong, Melissa V. Chan, Ruifang Lu, Xiaoke Yin, Filipe Gracio, Katarzyna Dudek, Sarah R. Langley, Anna Zampetaki, Emanuele de Rinaldis, Shu Ye, Timothy D. Warner, Alka Saxena, Stefan Kiechl, Robert F. Storey, Manuel Mayr
Circ Res. Author manuscript; available in PMC 2016 Oct 14.
Published in final edited form as: Circ Res. 2016 Feb 5; 118(3): 420–432. Published online 2015 Dec 8. doi: 10.1161/CIRCRESAHA.114.305663
PMCID:
PMC5065093
ArticlePDF–2.5M
14.
Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer
Mahito Miyamae, Shuhei Komatsu, Daisuke Ichikawa, Tsutomu Kawaguchi, Shoji Hirajima, Wataru Okajima, Takuma Ohashi, Taisuke Imamura, Hirotaka Konishi, Atsushi Shiozaki, Ryo Morimura, Hisashi Ikoma, Toshiya Ochiai, Kazuma Okamoto, Hiroki Taniguchi, Eigo Otsuji
Br J Cancer. 2015 Nov 17; 113(10): 1467–1476. Published online 2015 Oct 27. doi: 10.1038/bjc.2015.366
PMCID:
PMC4815891
ArticlePDF–1.0M
15.
MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway
Wei Zhou, Yongfeng Li, Shanmiao Gou, Jiongxin Xiong, Heshui Wu, Chunyou Wang, Haijiao Yan, Tao Liu
Oncotarget. 2015 Nov 10; 6(35): 37557–37569. Published online 2015 Oct 15. doi: 10.18632/oncotarget.5317
PMCID:
PMC4741948
ArticlePDF–6.2M
16.
MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5
Yuan Fang, Xiaoxia Zhu, Jian Wang, Na Li, Dianhe Li, Nazmus Sakib, Zhou Sha, Wen Song
Oncotarget. 2015 May 30; 6(15): 13164–13175. Published online 2015 Apr 18. doi: 10.18632/oncotarget.3754
PMCID:
PMC4537006
ArticlePDF–6.9M
17.
miR-744 enhances type I interferon signaling pathway by targeting PTP1B in primary human renal mesangial cells
Xiaoyan Zhang, Xiao Han, Yuanjia Tang, Yanfang Wu, Bo Qu, Nan Shen
Sci Rep. 2015; 5: 12987. Published online 2015 Aug 11. doi: 10.1038/srep12987
PMCID:
PMC4531339
ArticlePDF–1.2M
18.
Proto-oncogenic isoform A2 of eukaryotic translation elongation factor eEF1 is a target of miR-663 and miR-744
A Vislovukh, G Kratassiouk, E Porto, N Gralievska, C Beldiman, G Pinna, A El'skaya, A Harel-Bellan, B Negrutskii, I Groisman
Br J Cancer. 2013 Jun 11; 108(11): 2304–2311. Published online 2013 May 21. doi: 10.1038/bjc.2013.243
PMCID:
PMC3681015
ArticlePDF–467K
19.
Post-Transcriptional Regulation of Transforming Growth Factor Beta-1 by MicroRNA-744
John Martin, Robert H. Jenkins, Rasha Bennagi, Aleksandra Krupa, Aled O. Phillips, Timothy Bowen, Donald J. Fraser
PLoS One. 2011; 6(10): e25044. Published online 2011 Oct 4. doi: 10.1371/journal.pone.0025044
PMCID:
PMC3186795
ArticlePDF–971K
20.
miRBase: integrating microRNA annotation and deep-sequencing data
Ana Kozomara, Sam Griffiths-Jones
Nucleic Acids Res. 2011 Jan; 39(Database issue): D152–D157. Published online 2010 Oct 30. doi: 10.1093/nar/gkq1027
PMCID:
PMC3013655
ArticlePDF–5.1M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center